Takashi Nagao appointed president and chief executive officer of Medicago
Read more
-
-
Medicago signs agreements with the government of Canada to supply up to 76 million doses of its recombinant plant-derived COVID-19 vaccine
Read more -
Collaborative project of more than $1.2 million using artificial intelligence to optimize the production of vaccines, announced by CQDM and Medicago R&D
Read more -
A Medicago employee named one of CASCON X Evoke Canada’s Tech Titans: Top 19 of 2019
Read more -
Medicago awarded « Best New Vaccine Technology/Platform » at the World Vaccine Congress
Read more -
Medicago officially starts the construction of its site in Estimauville’s Innovation Area
Read more -
Medicago to build $245M production facility in Quebec City
Read more
